Project Grant R43DK145258
Award Date 9/12/25
Completion Date 8/31/26
Dollars Obligated $314K
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55414, USA
Similar Awards
- This Project Grant award of $356,032 from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847) supports the development of a novel bladder catheterization device. The project aims to create an innovative method for bladder drainage that addresses the significant morbidity and inconvenience associated with current catheterization approaches. Over 1 million Americans, including those with neurogenic bladder conditions, require catheter use for bladder drainage. The...
- This Project Grant award from the National Institute of Diabetes and Digestive and Kidney Diseases (CFDA 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research) provides $312,088 to Sojourn Medtech LLC to develop the CANSIM simulator. The CANSIM is a smart, personalized, and dialysis-specific training device to teach critical cannulation skills to dialysis nurses and patient care technicians. The key features include: 1) dialysis-specific design, 2) realistic and low-maintenance...
- This $550,000 Project Grant awarded by the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) supports the development of a remote monitoring system to reduce peritoneal dialysis (PD) infections. The project aims to create a medical device that can provide real-time, continuous monitoring of biomarkers in dialysate fluid to enable earlier detection and treatment of PD-associated infections. The key products and services to be delivered include: (1)...
- This federal Project Grant award of $737,949 from the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), supports research to modernize clinical methods for assessing fluid excess and removal during in-center hemodialysis treatment. The long-term goal is to improve patient-centered outcomes by leveraging newer techniques like multi-frequency bioelectrical impedance spectroscopy...
- This federal Project Grant award was provided by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847). The $306,867 award to Dupage Medical Technology Inc. supports the development of a new drug to treat ischemia-reperfusion injury associated with kidney transplantation. The project aims to develop a therapy that can reduce inflammation and thrombosis without causing excessive...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), through its Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), awarded a $350,000 Project Grant to Katharos, Inc. on Jun 20, 2025. The grant supports the development of a novel extracorporeal technology, the "Phosfilter" device, which aims to enhance phosphate removal from the blood of hemodialysis patients and reduce the incidence of high phosphate-associated morbidity and...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded a $437,010 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to the University of North Carolina at Chapel Hill. The grant, titled "Leveraging 'Smart Stent' Platform Technologies for AVF Maturation and More", aims to develop and test a biodegradable magnesium "smart stent" technology to improve early blood flow and minimize stenosis...
- This federal Project Grant award, funded by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847), is focused on developing a new class of biodegradable and elastic vascular grafts for hemodialysis. The $298,371 award to Anova Biomedical, Inc. aims to address the limitations of current expanded polytetrafluoroethylene (ePTFE) arteriovenous grafts, which have high failure rates...
- The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) awarded Emory University a $818,481 Project Grant under the Diabetes, Digestive, and Kidney Diseases Extramural Research program (CFDA 93.847) to conduct a longitudinal study on the quality of everyday life experiences among home dialysis patients and their family caregivers. The 5-year study, which began in September 2025, aims to characterize the quality of life and understand how home dialysis patients and their...
- This Project Grant award from the National Institute on Minority Health and Health Disparities (NIMHD), under the Minority Health and Health Disparities Research federal grant program (CFDA 93.307), provides $349,859 to Sojourn Medtech LLC to develop a patient-centered self-cannulation training simulator. The goal is to promote self-care and increase adoption of home hemodialysis among African American patients with end-stage renal disease (ESRD). The award period runs from September 17, 2025 to...